Dr Jeymi Tambiah is Chief Medical Officer at Eupraxia Pharmaceuticals, Seattle, WA, USA. He is a UK‑trained physician‑scientist with 18+ years of pharma and biotech experience, advancing programs from early phase clinical development through to commercialisation. His expertise spans novel therapeutics including first‑in‑class small molecules, biologics, and gene therapies across immunology, oncology, and neurology disease areas. He is a Fellow of the Academy of Physicians in Clinical Research (USA) and a Fellow of FPM UK, where he serves as North American representative on the FPM Global Forum and on the Membership Committee. At home he enjoys being dad to three teenagers, a cat and a dog.